PETROS PHARMACEUTICALS INC (PTPI) Stock Balance Sheet
NASDAQ:PTPI - Nasdaq - US71678J2096 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.71M | 13.34M | 9.43M | 23.85M | 17.14M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Receivables | 416.10K | 2.23M | 2.11M | 2.46M | 5.15M | |||
| Inventories | 1.35M | 1.61M | 1.82M | 520.00K | 760.00K | |||
| Other Current Assets | 1.82M | 3.22M | 1.31M | 3.72M | 2.85M | |||
| Total Current Assets | 7.29M | 20.39M | 14.67M | 30.54M | 25.91M | |||
| Non-Current Assets | ||||||||
| PPE Net | 136.70K | 255.20K | 400.00K | 520.00K | 640.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 3.20M | 8.97M | 12.24M | 25.29M | 32.16M | |||
| Other Non-Current Assets | 0.00 | 4.18M | 5.11M | 11.03M | 11.14M | |||
| Total Non-Current Assets | 3.34M | 13.41M | 17.75M | 36.85M | 43.94M | |||
| TOTAL ASSETS | 10.64M | 33.80M | 32.42M | 67.39M | 69.85M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 7.25M | 1.16M | 1.09M | 0.00 | 7.18M | |||
| Accrued Expenses | 8.36M | 7.46M | 3.62M | 23.54M | 26.73M | |||
| Accounts Payable | 2.33M | 1.71M | 1.81M | 4.56M | 5.61M | |||
| Other Current Liabilities | 89.50K | 444.00K | 550.00K | 2.88M | 2.38M | |||
| Total Current Liabilities | 18.03M | 10.77M | 7.07M | 30.98M | 41.89M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 6.86M | 8.39M | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 75.20K | 3.69M | 260.00K | 870.00K | 10.49M | |||
| Total Non-Current Liabilities | 75.20K | 10.54M | 8.65M | 870.00K | 10.49M | |||
| TOTAL LIABILITIES | 18.10M | 21.32M | 15.72M | 31.85M | 52.38M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -113.21M | -98.89M | -90.73M | -70.69M | -61.70M | |||
| Additional Paid In Capital | 105.74M | 110.96M | 107.43M | 106.23M | 79.17M | |||
| Common Shares | 1.10K | 409.30K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 421.10K | 119.70K | 83.20K | 82.70K | 38.80K | |||
| Tangible Book Value per Share | -25.34 | 25.90 | 53.62 | 123.88 | -378.32 | |||
| Total Shareholders' Equity | -7.47M | 12.48M | 16.70M | 35.54M | 17.47M | |||
| TOTAL LIABILITIES AND EQUITY | 10.64M | 33.80M | 32.42M | 67.39M | 69.85M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.55 | 0.50 | N/A | N/A | |||
| Current Ratio | 0.40 | 1.89 | 2.07 | 0.99 | 0.62 | |||
| Return On Assets (ROA) | -251.96% | -40.88% | -61.81% | -13.34% | -29.48% | |||
| Return On Equity (ROE) | N/A | -110.69% | -120.00% | -25.30% | -117.86% | |||
All data in USD , ROIC based on taxRate of 0.21